Summary of current clinical trials aiming to overcome radiation resistance in prostate cancer
| ClinicalTrials ID | Antigen target | Clincial phase | Study type | Number of patients | Response | Patients type |
|---|---|---|---|---|---|---|
| NCT05689021 | SPOP | Phase II | Interventional | 30 | On going | Castration-resistant prostate carcinoma; Metastatic prostate adenocarcinoma stage IVB; Prostate cancer AJCC V8 |
| NCT00085228 | Bcl-2 | Phase II | Interventional | 11 | Completed | Prostate cancer |
| NCT00666666 | Bcl-2 | Phase 2 | Interventional | 55 | Completed | Adenocarcinoma of the prostate; Stage IV prostate cancer |
| NCT04021394 | EMT | Not applicable | Observational | 31 | Completed | Prostate cancer |
| NCT02022904 | EMT | Not applicable | Interventional | 0 | Withdrawn | Prostate cancer |
| NCT02025413 | EMT | Not applicable | Observational | 46 | Completed | Metastatic progressive breast cancer; Metastatic progressive castration-resistant prostate cancer |